Residues of sulphadimidine and its metabolites in eggs following oral sulphadimidine medication of hens

The depletion of sulphadimidine (SDM) and its N4-acetyl and hydroxy metabolites was studied in eggs laid by hens after administration of either a single or multiple oral dosages of 100 mg SDM/kg. During medication and until 1 day after the last dose, the SDM and its metabolite concentrations in the egg white exceeded those in the egg yolk and reflected the plasma levels. In the period starting 2 days after the (last) dosage, the SDM concentration in the yolk became higher than in the egg white, and the drug depletion curves ran parallel. The mean maximum amount of SDM found in the whole egg was 1500 micrograms after a single and 1280 micrograms after multiple dosage. In eggs, traces of the N4-acetyl and 6-methylhydroxy metabolites could be detected (mainly in the egg white), and their concentrations were approximately 40 times lower than those of the parent drug. A highly significant correlation (P less than 0.005) was found between the development stage of the oocyte at the time of (last) medication and the amount of SDM found in the egg that developed from it. A period of 7 or 8 days after the (last) dosage of 100 mg SDM/kg/day is required to obtain SDM levels below 0.1 micrograms/g egg.     

Residue depletion of ampicillin in eggs

A residue depletion study of ampicillin (AMP) was performed after oral dosing (60.0 mg/kg and 120.0 mg/kg body weight once a day for 5 days) to laying hens, through the use of reversed‐phase high‐performance liquid chromatography with fluorescence detection (RP‐HPLC‐FLD) to achieve detection of ampicillin residue in eggs. Limit of detection was 0.5 ng/g, and limit of quantitation was 1.2 ng/g for ampicillin. Extraction recoveries of ampicillin from samples fortified at 5.0–125.0 ng/g levels ranged from 77.5% to 84.6% in albumen, 77.9% to 87.5% in yolk, and 77.9% to 88.6% in whole egg, with coefficients of variation ≤9.3%. The maximum concentrations of ampicillin in albumen, yolk, and whole egg were detected at 1, 2, and 1 day after the last administration of ampicillin, respectively. Ampicillin was not detectable in albumen at day 9 of withdrawal time, at day 10 and 11 in yolk, and day 9 and 11 in whole egg at each of those 2 dose levels. The theoretical withdrawal time of AMP in whole egg was 6.730 and 7.296 days for 60 and 120 mg/kg oral dosage, respectively. This method also proved to be suitable as a rapid and reliable method for the determination of ampicillin in other poultry eggs.     

Dose dependent disposition of sulphadimidine and of its N4‐acetyl and hydroxy metabolites in plasma and milk of dairy cows

Summary

The disposition of sulphadimidine (SDM) and of its N₄‐acetyl (N₄‐SDM) and two hydroxyl metabolites, 6‐hydroxymethyl‐ (SCH₂OH) and 5‐hydroxyasulphadimidine (SOH), was studied in plasma and milk of dairy cows following intramuscular or intravenous administration of sulphadimididine‐33.3% at doses of 10, 45, 50, and 100 mg/kg. The main metabolite in plasma as well as in milk was SCH₂OH. The metabolite percentages, the final plasma elimination half‐lives, and the time of peak SDM concentrations in milk are presented for different dosages. The concentrations of SDM and its metabolites in milk ran parallel to those in plasma beyond4 hours p.i. The metabolite concentrations in plasma and milk were lower than those of the parent SDM. Sulphate and glucuronide metabolites could not be detected in milk.

At high doses (45 mg/kg or more) and SDM plasma concentrations exceeding 20 μg/ml, a capacity limited metabolism of SDM to SCH₂OH was noticed, viz, asteady state concentration of SCH₂OH and a biphasic elimination pattern for SDM and SCH,OH in plasma and milk.

The mean ultrafiltrate ratios of the milk to plasma concentrations with respect to SDM, SCH₂OH, SOH, and N₄‐SDM were: 0.69, 0.22, 020, and 0.63, respectively.

The total amount of SDM and its metabolites recovered from the milk after milking twice daily over the whole experimental time was less than 2% of the applied dose.

A bioassay method allowed of detecting qualitatively SDM concentrations exceeding 0.2 μg/ml in plasma or milk. Withholding times for edible tissues and milk are suggested.     

Plasma disposition and renal clearance of sulphadimidine and its metabolites in laying hens

Plasma disposition of sulphadimidine (SDM) and its metabolites was studied in laying hens after 100 mg SDM kg-1 doses were administered as a single intravenous dose, a single oral dose and multiple oral doses once daily for five consecutive days. SDM was extensively metabolised by acetylation and hydroxylation. In plasma, the metabolite observed with the highest concentration was N4-acetylsulphadimidine (N4-SDM) followed by hydroxymethylsulphadimidine (CH2OH) and 5-hydroxysulphadimidine. Following intravenous administration a biphasic elimination (as seen for a capacity limited reaction) pattern for SDM and its metabolites was observed. Multiple (5x) SDM dosing revealed plasma SDM concentrations ranging between 7 and 108 micrograms ml-1; within 96 hours of termination of the multiple SDM dosing, the plasma SDM concentration was below 0.01 micrograms ml-1. The renal clearances of N4-SDM and the hydroxy metabolites were approximately 10 times greater than that of SDM. The SDM mass balance (faecal/urinary recovery) showed a loss of 56 per cent after intravenous dosage and of 67 per cent after a single oral dosage; the hydroxy metabolites accounted for the highest percentage in faeces/urine. Thus additional metabolic pathways must exist in laying hens.     

Pharmacokinetics,renal clearance,tissue distribution,and residue aspects of sulphadimidine and its N4‐acetyl metabolite in pigs

Summary

Pharmacokinetics and tissue distribution experiments were conducted in pigs to which sulphadimidine (SDM) was administered intravenously, orally, and intramuscularly at a dosage of 20 mg SDM/kg. SDM was acetylated extensively, but neither hydroxy metabolites nor their derivatives could be detected in plasma, edible tissues or urine. Following i.v. and two oral routes of administration, the N₄‐acetylsulphadimidine (N₄‐SDM) concentration‐time curve runs parallel to that of SDM. The percentage of N₄‐SDM in plasma was in the range between 7 and 13.5% of the total sulphonamide concentration. The bioavailability of SDM administered in a drench was 88.9 ± 5.4 % and administered mixed with pelleted feed for 3 consecutive days it was 48.0 ± 11.5 %. The renal clearance of unbound SDM, which was urine flow related, was 1/7 of that of creatinine, indicating reabsorption of the parent drug. The unbound N₄SDM was eliminated three times faster than creatinine, indicating that tubular secretion was the predominant mechanism of excretion.

After i.v. administration, 51.9 % of the administered dose was recovered in urine within 72 h p.i., one quarter of which as SDM and three quarters as N₄‐SDM.

Tissue distribution data obtained at 26, 74, 168, and 218 h after i.m. injection revealed that the highest SDM concentration was found in plasma. The SDM concentration in muscle, liver, and kidney ranged from one third to one fifth of that in plasma. The N₄‐SDM formed a minor part of the sulphonamide content in edible tissues, in which the SDM as well as the N₄‐SDM concentration parallelled the plasma concentrations.

Negative results obtained with a semi‐quantitative bioassay method, based on monitoring of urine or plasma, revealed that the SDM concentration levels in edible tissues were in that case below 0. 1μ/g tissue.     

Dynamics of amino acid and protein metabolism of laying hens after the administration of 15N-labeled wheat protein. 3. Incorporation of 15N into egg shell, egg white and egg yolk

12 colostomized laying hybrids received a ration meeting their requirement of 15N labelled wheat with a 15N excess (15N') of 14.37 atom-% over 4 days. The 15N' of the total ration amounted to 4.47 atom-%. Each hen consumed 135 mg 15N' per day. On another 4 days the same rations with non labelled wheat were fed. The 12 hens laid 56 eggs during the 8 days of the experiment. They were divided into egg shell, white and yolk of egg. In addition, the protein of the white and yolk of egg was precipitated with trichloric acetic acid (TCA) and the nitrogen in these fractions was determined. On average of the 56 eggs, the N quota in the egg shell was 5.3%, in the white of egg 49.1% and in the yolk 45.6%. The atom-% 15N' in the shells of the eggs laid on the first day of the experiment was on average 0.21, whereas only 0.03 and 0.02 atom-% 15N' resp. could be detected in the white and yolks of the eggs. On the first day after the last 15N application the atom-% 15N' in the egg shell and the white of egg was highest and amounted to 2.33 and 2.43 atom-% resp. The highest value of 1.83 atom-% 15N' in the yolk was ascertained 3 days after the last 15N intake. The mean quota of TCA-precipitable N in the white of egg is 97.6% and in the yolk 94.4% of the respective total N. The atom-% 15N' in the non-protein N-compounds was higher than in the protein fractions.     

Effects of Egg Yolk Source on the Cryopreservation of Stallion Spermatozoa

Three experiments were conducted to determine whether replacement of chicken egg yolk, as a component of freezing extenders, with egg yolk from other avian species would improve the post-thaw motility and percentage of intact acrosomes of stallion spermatozoa. In the first experiment, substitution of chicken egg yolk with chukar egg yolk, as a component of the lactose-ethylenediaminetetraacetic acid extender, improved (P ≤ .05) the post-thaw motility of stallion spermatozoa. These results were not replicated in (IMV Technologies, Maple Grove, MN, USA) a more expansive study comparing 2%, 4%, 6%, or 8% egg yolk combined with INRA 96 when a “slow freeze” method was used, or the same substitution at levels ranging from 13% to 22% when egg yolk was combined with lactose-ethylenediaminetetraacetic acid for diluents used for a “fast freeze” method of cryopreservation. In the third study, egg yolks from regular and high omega-3 chicken eggs as well as from turkey, chukar, and mallard duck eggs were analyzed for lipid content and fatty acid profile. The yolk from the turkey eggs was higher (1,300 mg/100 g) and that from mallard ducks was lower (560 mg/100 g) in cholesterol as compared with the two types of chicken eggs and chukar egg yolk (range, 1,046-1,094 mg/100 g). In addition, the high omega-3 eggs did test higher for fatty acids (4.51 g/100 g) than other types of eggs (range, 0.28-0.73 g/100 g). Substitution of chicken egg yolk with turkey, but not duck, egg yolk resulted in higher post-thaw total motility (P ≤ .05) for spermatozoa obtained from two of the three stallions used in the third experiment.     

Egg collagen content is increased by a diet supplemented with wood charcoal powder containing wood vinegar liquid

1. The aims of the present study were to examine whether collagen exists in egg, particularly in egg yolk; to establish a Fourier transform-near infrared (FT-NIR) measurement method for collagen in egg and to assess the possibility of increasing the collagen content by feeding hens a diet containing wood charcoal powder containing wood vinegar liquid (WCV).

2. The collagen in eggs from 67-week-old hens fed on the dietary 0 and 9.9 g/kg WCV diets was investigated using a combination of histochemical, matrix-assisted laser desorption ionisation with time-of-flight mass spectrometry (MALDI-TOF MS), Fourier transform infrared (FT-IR) and FT-NIR approaches.

3. All approaches used to identify collagen in egg yolk yielded positive results.

4. The collagen in egg yolk measured using colorimetry, collagen in egg yolk, egg white and eggshell membrane using FT-NIR and collagen in egg yolk determined by treating the egg yolk with collagenase were abundant after feeding a dietary WCV (p<0.05).

5. These results suggest that egg yolk contains collagen, that the collagen in egg can be measured using FT-NIR, and that the collagen content of egg yolk can be increased by feeding dietary WCV diets.

     

Albendazole treatment in laying hens: Egg residues and its effects on fertility and hatchability

This work characterized the egg residual concentrations of albendazole (ABZ ) and its sulphoxide (ABZSO ) and sulphone (ABZSO ₂) metabolites and evaluated their effect on egg fertility and hatchability after ABZ treatments to laying hens. Seventy hens were allocated in groups: Group‐1 was the control without treatment; Group‐2 received a single ABZ oral dose (10 mg/kg); Group‐3, ‐4 and ‐5 were treated with ABZ in medicated feed over 7 days at 10, 40, or 80 mg kg^?1 day^?1, respectively. Eggs were analyzed to determine the ABZ /metabolite level by HPLC or subjected to incubation to evaluate the fertility and hatchability. Only ABZSO and ABZSO ₂ metabolites were quantified in egg after ABZ single oral administration with maximum concentrations of 0.47 ± 0.08 and 0.30 ± 0.07 μg/ml, respectively. ABZ and its metabolites were found in eggs after 7‐day ABZ treatments. The egg residue exposure estimated as AUC s (areas under the concentration vs . time curve) were 100.5 (ABZ ), 56.3 (ABZSO ) and 141.3 μg hr g^?1 (ABZSO ₂). ABZ administration did not affect the egg fertility at any dosages. Egg hatchability was not affected by ABZ treatment at 10 mg/kg in medicated feed, but it decreased when the dose was 4–8 times higher. These results should be considered when ABZ is used for deworming laying hens.     

Pharmacokinetics and renal clearance of sulphadimidine,sulphamerazine and sulphadiazine and their N4‐acetyl and hydroxy metabolites in pigs

Summary

The effect of molecular structure on the drug disposition and protein binding in plasma, the urinary recovery, and the renal clearance of sulphamerazine (SMR), sulphadiazine (SDZ), and sulphadimidine (SDM) and their N₄‐acetyl and hydroxy derivatives were studied in pigs. Following IV administration of SDM, SMR and SDZ, their mean elimination half‐lives were 12.4 h, 4.3 h and 4.9 h respectively. The plasma concentrations of parent sulphonamide were higher than those of the metabolites, and ran parallel. The acetylated derivatives were the main metabolites; traces of 6‐hydroxymethylsulphamerazine and 4‐hydroxysulphadiazine were detected in plasma.

The urine recovery data showed that in pigs acetylation is the major elimination pathway of SDM, SMR and SDZ; hydroxylation became more important in case of SMR (6‐hydroxymethyl and 4‐hydroxy derivatives) and SDZ (4‐hydroxy derivatives) than in SDM. In pigs methyl substitution of the pyrimidine side chain decreased the renal clearance of the parent drug and made the parent compound less accessible for hydroxylation. Acetylation and hydroxylation speeded up drug elimentation, because their renal clearance values were higher than those of the parent drug.     

Nonlinear pharmacokinetics of intravenous sulphadimethoxine and its dosage regimen in pigs

Summary

The time courses of the total (Ct) and unbound plasma (Cf) concentration after the i.v. injection of 20, 50 and 100 mg/kg of sulphadimethoxine (SDM) were examined in pigs;

The area under the Ct‐time curve per unit dose decreased dose‐dependently. Vd_area and total body clearance of Ct increased dose‐dependently.

The concentration‐dependent plasma protein binding of SDM was evident after 50 and 100 mg/kg.

The time courses of Cf en Ct after 3 doses were analysed by a one compartment open model with nonlinear plasma protein binding. The agreement between calculated curves of Cf and Ct and the observed values, and relative constancy of pharmacokinetic parameters were obtained over 3 doses. These results suggested that the nonlinear pharmacokinetics of SDM was caused by saturable plasma protein binding.

The multiple i.v. dose of SDM was based on the dosage regimen using the nonlinear pharmacokinetic model (50 mg/kg, 24 hour interval, 4 days). The observed Cf was maintained in the intended range by the dosage regimen. Therefore, the dosage regimen based on the nonlinear pharmacokinetics may allow the unbound concentration after i.v. injection of SDM in pigs to be controlled.     

Pharmacokinetics of sulphanilamide and its three acetyl metabolites in dairy cows and calves

Summary

An intravenous low dosage of sulphanilamide (SAA) (14.0 mg/kg) to 6 pre‐ruminant calves revealed a biphasic SAA plasma disposition with a mean elimination half‐life of 4.1 h. The main metabolite in plasma was N₄‐acetylsulphanilamide (N₄), which 4 hours after injection exceeded the parent SAA plasma concentration. Urinary recovery of SAA was 10 to 16% of the dose; of N₄, it was at least 69%. Traces of the N₁‐acetyl (N₁) metabolite and the doubly acetylated derivative (N₁N₄) were present in urine. The renal clearances of the N₁ and N₄ metabolites showed a tubular secretion pattern, which was at least 2 to 6 times higher than that of SAA.

A single high oral SAA dose of 200 mg/kg to 3 dairy cows resulted in extensive metabolism of SAA into N₄ N₁, and N₁N₄ metabolites; their mean maximum plasma concentrations were 64, 48, 0.72 and 24 μg/ml, respectively. The mean disposition half‐life of SAA in plasma and milk was 10 h. In milk the metabolite concentrations exceeded those in plasma; the N₄ and N₁N₄ metabolite concentrations in milk exceeded that of SAA. The mean maximum concentrations of SAA, N₄, N₁, and N₁N₄ in milk were 52, 89, 2.3, and 98 pg/ml. respectively. For SAA and its metabolites, the binding to plasma and milk proteins was determined. No glucuronide or sulphate conjugates of SAA and its acetyl metabolites could be found in plasma, milk, or urine.

Based on the sensitivity of the bioassay (0.2 μg SAA/ml), a withholding time of 5 days was suggested for milk following single oral SAA dosage of 200 mg/kg.     

不同品种、不同周龄鸡蛋营养成分比较研究

本试验选用北京油鸡、白来航、海兰褐3个品种,每个品种随机挑选17或19周龄(北京油鸡)、42周龄、70周龄母鸡收集鸡蛋进行蛋黄营养成分的测定。结果表明:不同品种3个产蛋时期的蛋黄比例、蛋白比例、蛋黄维生素E含量都有极显著差异(P<0.01)。其中白来航、海兰褐在不同产蛋时期的蛋黄、蛋白比例呈现相同的变化趋势,即蛋黄比例为70周龄蛋最高,蛋白比例为初产蛋最高。3个品种不同产蛋时期维生素E含量变化亦势趋相同,初产蛋最高。3个品种42周龄蛋中的必需氨基酸比例显著高于其他2个时间点(P<0.01)。商业品种与中国地方鸡种所产蛋在蛋黄、蛋白比例、维生素B2变化趋势迥异,无统一规律可循。     

Dietary levels of chia: influence on hen weight,egg production and sensory quality,for two strains of hens

1. Laying hens, 225 white and 225 brown, were fed for 90 d to compare a control diet with diets containing 70, 140, 210 and 280 g/kg chia (Salvia hispanica L.) seed. 2. Hen weight was not significantly affected by diet; however, manure production was less for the hens fed on chia. 3. Egg weight and production, yolk weight, and yolk percentage were determined at d 0, 30, 43, 58, 72 and 90. 4. A sensory evaluation was conducted on eggs produced during the last week of the trial. 5. No significant differences in egg production were found among treatments for the brown hens. 6. With the 280 g/kg chia diet, the white hens produced fewer and lighter eggs than did the hens fed on the control diet. 7. No significant differences were detected in yolk weight until d 90. 8. On this date the yolks produced by the white hens fed on the 70 g/kg chia diet were significantly lighter in weight, whereas the brown hens produced significantly heavier yolks, compared with the hens fed on the control diet. 9. Yolk weight as a percentage of egg weight was lower for white hens throughout the trial except on d 58 with the 140 g/kg chia diet. Significant differences, however, were detected only with the 70 g/ kg chia diet on d 90 and with the 210 g/kg chia diet on d 58, 72 and 90. 10. No significant differences in taste preference or flavour were found among any of the chia treatments and the control.     

Reduced egg shell permeability affects embryonic development and hatchling traits in Lycodon rufozonatum and Pelodiscus sinensis

The response of embryos to unpredictable hypoxia is critical for successful embryonic development, yet there remain significant gaps in our understanding of such responses in reptiles with different types of egg shell. We experimentally generated external regional hypoxia by sealing either the upper half or bottom half of the surface area of eggs in 2 species of reptiles (snake [Lycodon rufozonatum] with parchment egg shell and Chinese soft‐shelled turtle [Pelodiscus sinensis] with rigid egg shell), then monitored the growth pattern of the opaque white patch in turtle eggs (a membrane that attaches the embryo to the egg shell and plays an important role in gas exchange), the embryonic heart rate, the developmental rate and the hatchling traits in turtle and snake eggs in response to external regional hypoxia. The snake embryos from the hypoxia treatments facultatively increased their heart rate during incubation, and turtle embryos from the upper‐half hypoxia treatment enhanced their growth of the opaque white patch. Furthermore, the incubation period and hatching success of embryos were not affected by the hypoxia treatment in these 2 species. External regional hypoxia significantly affected embryonic yolk utilization and offspring size in the snake and turtle. Compared to sham controls, embryos from the upper‐half hypoxia treatment used less energy from yolk and, therefore, developed into smaller hatchlings, but embryos from the bottom‐half hypoxia treatment did not.     

Beta‐carotene supplementation of Laying Hen Diets

1. The possibility of β‐carotene affecting production of hens or hatchability of eggs was studied over 252 d with diets based on white maize containing 0, 1·5, 6·75 or 15 mg added β‐carotene/kg.

2. Egg production, food intake, food utilisation, egg weight, and egg specific gravity were not affected significantly by jS‐carotene. Egg fertility, hatch‐ability and final body weights of hens were also not significantly influenced.

3. Reflectance measurements showed that dietary β‐carotene resulted in increased deposition and more intense pigmentation in the egg yolk.

     

Effect of hesperidin dietary supplementation on hen performance,egg quality and yolk oxidative stability

1. The purpose of this study was to evaluate the effects of dietary supplementation with hesperidin (one or 3 g/kg of feed) for 31 d on the performance, egg quality and yolk oxidative stability of brown and white laying hens (26-wk old).

2. Supplementation with hesperidin did not affect egg production, egg weight and egg quality traits.

3. No hesperidin effect on yolk and plasma cholesterol was observed. A strain effect was found with lower total and per g yolk cholesterol of brown hens in comparison to the white ones.

4. Oxidative stability of egg yolk, expressed as ng MDA/g yolk, was significantly improved in the hesperidin groups even from the first week of supplementation. At the same time, a significant improvement in the oxidative stability of egg yolk due to the incorporation of hesperidin in hens’ diet was observed after 30 and 90 d of storage at 20°C and 4°C, respectively.

5. No hesperidin by strain interaction was detected for any of the traits measured.

6. In conclusion, incorporation of hesperidin to laying hens’ feed did not affect productive and egg qualitative traits. On the other hand, dietary hesperidin supplementation significantly improved oxidative stability of both fresh and stored eggs. Antioxidant properties of hesperidin seem to make it a promising natural agent for improving the shelf life of eggs.     

Egg discolouration effects of including screw‐press cottonseed meal in laying hen diets and their prevention

The egg discolouration effects of including a screw‐press cottonseed meal (CSM), containing 68.2 g residual lipid/kg, 290 mg cyclopropenoid fatty acids (CPFA)/kg and 1226 mg free gossypol/kg, in laying hen diets at 300 g/kg were examined.

2. Discolouration prevention methods included treating the meal with ferrous sulphate heptahydrate (FSH), in solution or as crystals, at a 4:1 weight ratio of iron to free gossypol (experiment 1), and reducing its residual lipid (CSL) content to 4.2 g/kg by hexane extraction (experiment 2).

3. In freshly laid eggs, no discolouration was observed when hens were fed a CSM‐based diet containing 250 mg free gossypol/kg and 87 mg CPFA/kg in experiment 1, but slightly brown yolks were produced in experiment 2.

4. Storage of the eggs at 22°C led to yolk mottling, an effect believed to be the initial stages of the brown yolk discolouration.

5. Storage of the eggs at 5°C resulted in enhancement of the brown yolk discolouration, apricot discolouration on surfaces of most yolks and pink albumen discolouration. These effects were prevented when the CSM was extracted with hexane. Apricot yolk and pink albumen discolourations were also produced when hens were fed a non‐CSM diet containing crude CSL at 20.5 g/kg.

6. Dietary CSL increased egg fat saturation, altering the ratios of stearic to oleic, palmitic to palmitoleic and heptadecanoic to hepta‐decenoic fatty acids.

7. Treatment of CSM with FSH reduced the slight brown yolk discolouration in fresh eggs (experiment 2) and the yolk mottling in warm‐stored eggs. Both in solution and as crystals, FSH prevented the enhancement of brown yolk discolouration in cold‐stored eggs, leaving most eggs with apricot yolk and pink albumen discolourations.

8. Treatment of CSM and CSL with FSH reduced the CPFA‐related effects on yolk fat saturation, and the colour and pH changes in cold‐stored eggs.

9. Exposure of yolks to ammonia vapour provided a useful test to predict the development of the gossypol‐related brown discolouration in stored eggs.     

Utilization of 15N marked urea by the laying hen. 2. Incorporation and metabolism of 15N for the synthesis of egg protein

In an N-metabolism experiment 3 colostomized laying hybrids received 2870 mg 15N-excess (15N') per animal in 6 days in the form of urea with their conventional feed rations. During the 8-day experiment the 21 eggs laid were separated into eggshell, white of egg and yolk. Weight, N-content and 15N' were determined of the individual fractions of the eggs. On an average of the 21 eggs 4.6% of the heavy nitrogen was in the egg-shells, 50% in the white of egg and 45.5% in the yolk. 2.8%, 4.5% and 5.5% (hens 1...3) of the 15N' consumed were detected in the eggs. The maximum 15N'-output in the white of egg was reached on the 6th day, whereas 15N'-output in the yolk showed a nearly linear increase in the time of the experiment. The results show that labelled nitrogen from urea is incorporated into the egg to a lower degree than after the feeding of 15N-labelled proteins and that the development of its incorporation into the white of egg and the yolk differ from that after the feeding of 15N-labelled native proteins.